Health care stocks were flat to lower pre-bell Thursday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was down 0.5% recently.
Elevance Health (ELV) shares fell past 13% after the company reported Q3 adjusted earnings of $8.37 per diluted share, down from $8.99 a year earlier. The company also lowered its 2024 adjusted EPS outlook.
Capricor Therapeutics (CAPR) shares declined by 6% after the company priced an underwritten offering of about 4.4 million shares at $17 per share for expected gross proceeds of about $75 million.
Travere Therapeutics (TVTX) shares were over 2% higher after the company said Swissmedic offered a temporary marketing approval for Filspari to treat adults with primary IgA nephropathy with a urine protein excretion of at least 1 gram per day.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。